Despite the lack of deep value, there is something else: Akero Therapeutics Inc (AKRO) Stock
Cantor Fitzgerald raised the price target for the Akero Therapeutics Inc (NASDAQ:AKRO) stock to “an Overweight”. The rating was released on September 19, 2023, according to finviz. The research report from Morgan Stanley has upgraded the stock from Equal-Weight to Overweight, with a price target set at $65. The stock was upgraded by Evercore ISI, […]
What does the future hold for Akero Therapeutics Inc (AKRO) Stock?
Cantor Fitzgerald raised the price target for the Akero Therapeutics Inc (NASDAQ:AKRO) stock to “an Overweight”. The rating was released on September 19, 2023, according to finviz. The research report from Morgan Stanley has upgraded the stock from Equal-Weight to Overweight, with a price target set at $65. The stock was upgraded by Evercore ISI, […]
Despite the lack of deep value, there is something else: Akero Therapeutics Inc (AKRO) Stock
Cantor Fitzgerald raised the price target for the Akero Therapeutics Inc (NASDAQ:AKRO) stock to “an Overweight”. The rating was released on September 19, 2023, according to finviz. The research report from Morgan Stanley has upgraded the stock from Equal-Weight to Overweight, with a price target set at $65. The stock was upgraded by Evercore ISI, […]
If you still want to check out Akero Therapeutics Inc (AKRO) Stock, you should do so again
Cantor Fitzgerald raised the price target for the Akero Therapeutics Inc (NASDAQ:AKRO) stock to “an Overweight”. The rating was released on September 19, 2023, according to finviz. The research report from Morgan Stanley has upgraded the stock from Equal-Weight to Overweight, with a price target set at $65. The stock was upgraded by Evercore ISI, […]
Consensus Analyst Estimated Price Target of $51.25 for Akero Therapeutics Inc (NASDAQ:AKRO) Stock
Cantor Fitzgerald raised the price target for the Akero Therapeutics Inc (NASDAQ:AKRO) stock to “an Overweight”. The rating was released on September 19, 2023, according to finviz. The research report from Morgan Stanley has upgraded the stock from Equal-Weight to Overweight, with a price target set at $65. The stock was upgraded by Evercore ISI, […]
It’s an all-out bull run for Akero Therapeutics Inc (AKRO) Stock
Cantor Fitzgerald raised the price target for the Akero Therapeutics Inc (NASDAQ:AKRO) stock to “an Overweight”. The rating was released on September 19, 2023, according to finviz. The research report from Morgan Stanley has upgraded the stock from Equal-Weight to Overweight, with a price target set at $65. The stock was upgraded by Evercore ISI, […]
Akero Therapeutics Inc (NASDAQ:AKRO) stock Posted Operating Margin of 0.00 percent in Last Year: Is Admissible?
Cantor Fitzgerald raised the price target for the Akero Therapeutics Inc (NASDAQ:AKRO) stock to “an Overweight”. The rating was released on September 19, 2023, according to finviz. The research report from Morgan Stanley has upgraded the stock from Equal-Weight to Overweight, with a price target set at $65. The stock was upgraded by Evercore ISI, […]
Akero Therapeutics Inc (NASDAQ:AKRO) stock is trading -52.83 percent below its 52-week high
Cantor Fitzgerald raised the price target for the Akero Therapeutics Inc (NASDAQ:AKRO) stock to “an Overweight”. The rating was released on September 19, 2023, according to finviz. The research report from Morgan Stanley has upgraded the stock from Equal-Weight to Overweight, with a price target set at $65. The stock was upgraded by Evercore ISI, […]
